Rise rebrands New York license to Fiorello Pharmaceuticals, Inc.

Rise has changed its New York licensee name to Fiorello Pharmaceuticals, Inc., per state roster update.

The Cannabis Newz Automated Desk

Machine-written from our data · source: State license roster

August 28, 2026 · 9:38 AM ET

Business handshake in an office — file photo, not the scene of this story.

Rise has formally rebranded its New York cannabis license under the name Fiorello Pharmaceuticals, Inc., according to the state license roster. The change appears part of a broader wave of ownership and entity restructuring across New York's adult-use market—state records show at least five other licensees undergoing name changes within a 24-hour window ending Aug. 28.

The rebranding occurs against a backdrop of mixed market signals. New York's adult-use retail footprint stands at 877 open dispensaries with 416 pending applications, while five cultivation and retail entities lost their licenses in the past two days. Rise's current active licenses under related entities include adult-use retail and conditional retail dispensary permits.

Watch whether the rebranding signals a shift in Rise's operational or ownership structure, and whether similar entity-name changes correlate with license renewals, compliance updates, or equity program transitions in the state.

Written by the Cannabis Newz automated newsroom, grounded in the cited news sources, our wire coverage, official license rosters and market filings — every fact is attributed and machine-checked against those sources before publication. Spotted an error? Tell us via your account page.